🚀 VC round data is live in beta, check it out!
Cannovum Cannabis Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cannovum Cannabis and similar public comparables like Stayble Therapeutics, Respiratorius, PharmaLundensis, Reboost Blockchain and more.
Cannovum Cannabis Overview
About Cannovum Cannabis
Cannovum Cannabis AG is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. It focuses on the import of medical cannabis, medical-scientific education, and distribution for facilitated access to cannabis-based therapies.
Founded
N/A
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$1M
Cannovum Cannabis Financials
Cannovum Cannabis reported last fiscal year revenue of — and negative EBITDA of ($202K).
In the same fiscal year, Cannovum Cannabis generated ($202K) in EBITDA losses and had net loss of ($466K).
Revenue (LTM)
Cannovum Cannabis P&L
In the most recent fiscal year, Cannovum Cannabis reported revenue of — and EBITDA of ($202K).
Cannovum Cannabis expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($202K) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($466K) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cannovum Cannabis Stock Performance
Cannovum Cannabis has current market cap of $1M, and enterprise value of $1M.
Market Cap Evolution
Cannovum Cannabis' stock price is $0.55.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $1M | 0.8% | XXX | XXX | XXX | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCannovum Cannabis Valuation Multiples
Cannovum Cannabis trades at (6.4x) EV/EBITDA.
EV / Revenue (LTM)
Cannovum Cannabis Financial Valuation Multiples
As of March 11, 2026, Cannovum Cannabis has market cap of $1M and EV of $1M.
Equity research analysts estimate Cannovum Cannabis' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cannovum Cannabis has a P/E ratio of (2.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (6.4x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (6.3x) | XXX | XXX | XXX |
| P/E | — | XXX | (2.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cannovum Cannabis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cannovum Cannabis Margins & Growth Rates
Cannovum Cannabis' revenue in the last fiscal year declined by (100%).
Cannovum Cannabis Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 177% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cannovum Cannabis Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Stayble Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Respiratorius | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmaLundensis | XXX | XXX | XXX | XXX | XXX | XXX |
| Reboost Blockchain | XXX | XXX | XXX | XXX | XXX | XXX |
| GeNeuro | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cannovum Cannabis M&A Activity
Cannovum Cannabis acquired XXX companies to date.
Last acquisition by Cannovum Cannabis was on XXXXXXXX, XXXXX. Cannovum Cannabis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cannovum Cannabis
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCannovum Cannabis Investment Activity
Cannovum Cannabis invested in XXX companies to date.
Cannovum Cannabis made its latest investment on XXXXXXXX, XXXXX. Cannovum Cannabis invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cannovum Cannabis
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cannovum Cannabis
| Where is Cannovum Cannabis headquartered? | Cannovum Cannabis is headquartered in Germany. |
| Is Cannovum Cannabis publicly listed? | Yes, Cannovum Cannabis is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Cannovum Cannabis? | Cannovum Cannabis trades under 27N0 ticker. |
| When did Cannovum Cannabis go public? | Cannovum Cannabis went public in 2022. |
| Who are competitors of Cannovum Cannabis? | Cannovum Cannabis main competitors are Stayble Therapeutics, Respiratorius, PharmaLundensis, Reboost Blockchain. |
| What is the current market cap of Cannovum Cannabis? | Cannovum Cannabis' current market cap is $1M. |
| Is Cannovum Cannabis profitable? | No, Cannovum Cannabis is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.